vs

Side-by-side financial comparison of FINANCIAL INSTITUTIONS INC (FISI) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $62.7M, roughly 1.3× FINANCIAL INSTITUTIONS INC). FINANCIAL INSTITUTIONS INC runs the higher net margin — 33.5% vs -38.1%, a 71.5% gap on every dollar of revenue. Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -2.0%).

The Mizuho Financial Group, Inc. , known from 2000 to 2003 as Mizuho Holdings and abbreviated as MHFG or simply Mizuho, is a Japanese banking holding company headquartered in the Ōtemachi district of Chiyoda, Tokyo, Japan. The group was formed in 2000–2002 by merger of Dai-Ichi Kangyo Bank, Fuji Bank, and Industrial Bank of Japan. The name mizuho (瑞穂) literally means "abundant rice" in Japanese and "harvest" in the figurative sense.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

FISI vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.3× larger
PRCT
$83.1M
$62.7M
FISI
Higher net margin
FISI
FISI
71.5% more per $
FISI
33.5%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-2.0%
FISI

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
FISI
FISI
PRCT
PRCT
Revenue
$62.7M
$83.1M
Net Profit
$21.0M
$-31.6M
Gross Margin
64.9%
Operating Margin
-4.1%
Net Margin
33.5%
-38.1%
Revenue YoY
20.2%
Net Profit YoY
24.3%
-27.9%
EPS (diluted)
$1.04
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FISI
FISI
PRCT
PRCT
Q1 26
$62.7M
$83.1M
Q4 25
$64.1M
$76.4M
Q3 25
$63.8M
$83.3M
Q2 25
$59.7M
$79.2M
Q1 25
$57.2M
$69.2M
Q4 24
$41.6M
$68.2M
Q3 24
$50.1M
$58.4M
Q2 24
$65.2M
$53.4M
Net Profit
FISI
FISI
PRCT
PRCT
Q1 26
$21.0M
$-31.6M
Q4 25
$20.0M
$-29.8M
Q3 25
$20.5M
$-21.4M
Q2 25
$17.5M
$-19.6M
Q1 25
$16.9M
$-24.7M
Q4 24
$-82.8M
$-18.9M
Q3 24
$13.5M
$-21.0M
Q2 24
$25.6M
$-25.6M
Gross Margin
FISI
FISI
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
FISI
FISI
PRCT
PRCT
Q1 26
-4.1%
Q4 25
37.4%
-40.6%
Q3 25
39.5%
-27.8%
Q2 25
36.0%
-28.0%
Q1 25
36.0%
-39.7%
Q4 24
-276.9%
-28.9%
Q3 24
29.0%
-38.4%
Q2 24
46.2%
-50.3%
Net Margin
FISI
FISI
PRCT
PRCT
Q1 26
33.5%
-38.1%
Q4 25
38.3%
-39.1%
Q3 25
32.1%
-25.7%
Q2 25
29.3%
-24.7%
Q1 25
29.5%
-35.8%
Q4 24
-198.9%
-27.6%
Q3 24
26.9%
-35.9%
Q2 24
39.3%
-48.0%
EPS (diluted)
FISI
FISI
PRCT
PRCT
Q1 26
$1.04
$-0.56
Q4 25
$0.96
$-0.54
Q3 25
$0.99
$-0.38
Q2 25
$0.85
$-0.35
Q1 25
$0.81
$-0.45
Q4 24
$-5.32
$-0.34
Q3 24
$0.84
$-0.40
Q2 24
$1.62
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FISI
FISI
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$85.5M
$245.6M
Total DebtLower is stronger
$114.0M
$51.7M
Stockholders' EquityBook value
$347.7M
Total Assets
$6.3B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FISI
FISI
PRCT
PRCT
Q1 26
$85.5M
$245.6M
Q4 25
$108.8M
$286.5M
Q3 25
$185.9M
$294.3M
Q2 25
$93.0M
$302.7M
Q1 25
$167.4M
$316.2M
Q4 24
$87.3M
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
FISI
FISI
PRCT
PRCT
Q1 26
$114.0M
$51.7M
Q4 25
$193.7M
$51.6M
Q3 25
$115.0M
$51.6M
Q2 25
$115.0M
$51.5M
Q1 25
$124.9M
$51.5M
Q4 24
$124.8M
$51.5M
Q3 24
$124.8M
$51.4M
Q2 24
$124.7M
$51.4M
Stockholders' Equity
FISI
FISI
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$628.9M
$365.9M
Q3 25
$621.7M
$380.3M
Q2 25
$601.7M
$385.8M
Q1 25
$589.9M
$389.2M
Q4 24
$569.0M
$402.2M
Q3 24
$500.3M
$241.2M
Q2 24
$467.7M
$251.8M
Total Assets
FISI
FISI
PRCT
PRCT
Q1 26
$6.3B
$487.1M
Q4 25
$6.3B
$508.1M
Q3 25
$6.3B
$511.5M
Q2 25
$6.1B
$513.1M
Q1 25
$6.3B
$519.4M
Q4 24
$6.1B
$534.0M
Q3 24
$6.2B
$374.1M
Q2 24
$6.1B
$374.4M
Debt / Equity
FISI
FISI
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.31×
0.14×
Q3 25
0.18×
0.14×
Q2 25
0.19×
0.13×
Q1 25
0.21×
0.13×
Q4 24
0.22×
0.13×
Q3 24
0.25×
0.21×
Q2 24
0.27×
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FISI
FISI

Net Interest Income$52.0M83%
Noninterest Income$10.7M17%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons